Any degree (moderate/severe) | ||
---|---|---|
Donepezil (n=14*) | Placebo (n=12) | |
*14 patients received donepezil treatment, but only 12 received placebo treatment because two patients dropped out. | ||
Nausea | 4 (3) | 2 (1) |
Headache | 4 (3) | 3 (1) |
Tiredness | 7 (6) | 6 (5) |
Insomnia | 2 (1) | 2 (1) |
Increased dreaming | 3 (2) | 5 (2) |
Dizziness | 7 (3) | 3 (1) |
Increased sweating | 6 (5) | 3 (2) |
Increased salivation | 6 (4) | 4 (1) |
Dry mouth | 4 (2) | 5 (2) |
Diarrhoea | 2 (2) | 2 (1) |
Constipation | 5 (2) | 4 (0) |
Urinary retention | 0 | 0 |
Rash | 3 (0) | 0 |
Any adverse event | 12 (11) | 9 (7) |
Number of adverse events per person, mean (SD) | 4.2 (3.2) | 2.8 (1.0) |